InDevR raises $7M in series A round with Adjuvant Capital investment

InDevR raises $7M in series A round with Adjuvant Capital investment

BOULDER -- InDevR, Inc. , a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced it has raised... Read More

Tuesday September 10, 2019 0 comments Tags: Boulder, InDevR, Adjuvant Capital, Glenn Rockman, Kathy Rowlen

InDevR appoints Dawn Bitz chief commercial officer

InDevR appoints Dawn Bitz chief commercial officer

BOULDER -- InDevR , a Boulder-based progressive analytical technology, life science instrumentation and medical device company, announced the appointment of Dawn Bitz as VP, Chief Commercial... Read More

Wednesday June 29, 2016 0 comments Tags: Boulder, InDevR, Dawn Bitz, Kathy Rowlen